IMPORTANT COVID INFORMATION: In an effort to ensure safety for our attendees and staff, this conference will be requiring attendees to show proof of COVID-19 vaccination at the conference. The conference will also be providing mandatory rapid COVID-19 testing upon arrival, prior to entering the event.



BioMed Realty, a Blackstone portfolio company, is a leading provider of real estate solutions to the life science and technology industries. BioMed owns and operates high quality life science real estate comprising 13.7 million square feet concentrated in leading innovation markets throughout the United States and United Kingdom, including Boston/Cambridge, San Francisco, San Diego, Seattle and Cambridge, U.K. In addition, BioMed maintains a premier development platform with 2.3 million square feet of Class A properties in active construction to meet the growing demand of the life science industry. To learn more about BioMed Realty, visit

Eversheds Sutherland’s California life sciences intellectual property team, based in San Diego, is part of a robust US and global IP practice, and is backed by a top 10 powerhouse law firm spanning 34 countries and representing many pharmaceutical, medical device, and biotech companies and institutions. We are committed to helping emerging life sciences companies thrive and grow, and providing full-circle consulting and legal services to your best advantage. Learn more




Latham is one of the largest law firms in the world with more than 3,000+ lawyers located in major financial, business and regulatory centers around the globe. We have one of the most integrated and comprehensive life sciences practices in the world, with more than 30 years of experience representing life sciences companies. We understands the economic, market, regulatory, enforcement, and political climates in which life sciences companies operate, and work seamlessly across offices and borders to provide integrated solutions for clients’ legal and business needs. For more information on Latham & Watkins, please visit the website at


LifeSci Partners: Founded in 2009, by Andrew McDonald PhD and Michael Rice, LifeSci Partners is a leading provider of strategic healthcare advisory services in the areas of Investor Relations, Communications, Venture Investing, Partnering & Analytics, Capital Market Services, Executive Search and On Demand Talent. With global presences in New York, Boston, San Francisco / Silicon Valley, Chicago, Charlotte, London, Geneva, Paris, Milan, and Tel-Aviv, LifeSci Partners leverages its relationships and local knowledge in multiple territories around the world to provide high value services for clients. To learn more, please visit us at


Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at and



Merck & Co., Inc., Kenilworth, New Jersey, USA is known as MSD outside of the United States and Canada.

Merck has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. With more than 100 significant business development transactions since 2017, our team has experience working on collaborations from discovery through clinical-stage programs.

We believe that by working together we can play a major role in transforming global health care. Together we can invent for life. Learn more at

Morrison & Foerster leads the legal field in representing groundbreaking innovators at the convergence of the life sciences, healthcare, and technology industries. Globally recognized for our work with biotech, pharmaceutical, and medical device leaders and investors as well as research institutions around the world, we help clients bring new, game-changing solutions to the healthcare marketplace. Our Life Sciences & Healthcare Group includes attorneys, patent agents, and scientific advisors with 100+ advanced scientific and engineering degrees, including 65 Ph.D.s in life sciences and related engineering disciplines. As trusted business advisors, we provide strategic counsel on emerging company/venture capital, corporate mergers & acquisitions, intellectual property strategy, FDA regulatory and compliance, privacy, collaborations and joint ventures, technology transactions and licensing, and litigation. From conception to commercialization and exit, our collaborative, cross-disciplinary team focuses on what drives your business and helps to develop the strategies that lead to growth and commercial success. Learn more here


Perkins Coie has built a premier law firm by immersing ourselves in our clients’ technologies. Whether building strategic patent portfolios or prosecuting, guiding regulatory compliance, or defending and enforcing quality patents that consistently withstand challenges, we represent life sciences leaders and emerging innovators. We also help create new opportunities steering clients’ venture capital financings, IPOs, licensing agreements and other defining transactions. A number of our attorneys have advanced degrees in science or engineering.


Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit



The Sanford Stem Cell Clinical Center at UC San Diego Health accelerates the development of drugs and cell therapies inspired by and derived from current human stem cell research. These advancements establish, promote, and disseminate clinical trials and patient therapies that will help more quickly transform promise into reality.


Wilson Sonsini’s life sciences practice offers a multi-disciplinary team of attorneys, patent agents, and scientific advisors. Our professionals work with scientists, entrepreneurs, and investors who have helped develop innovative discoveries in nearly every field of medicine and healthcare, from genomics, immuno-oncology and pharmaceuticals, to diagnostics and synthetic biology. We represent clients in a wide range of strategic and operational corporate areas and help them with complex commercial and tech transactions driven by IP and innovation.



Amgen Business Development creates opportunities that leverage our unique capabilities with innovative technologies and therapies of our partners to deliver life changing therapies for patients with serious illnesses. By bringing together deep scientific, financial, deal, partnership, and integration expertise, Business Development plays a critical role in the execution of Amgen’s growth strategy and effectively manages the process of working with partners, from funding early-stage innovation to integration and alliance management once an agreement is executed. 


Halloran Consulting Group is a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support to industry leaders and startup visionaries in the pharmaceutical, biotechnology, and medical device sectors. Our consultants are subject matter experts who deliver a tailored approach to each engagement, successfully propelling our clients to their next inflection point. We connect clients with our trusted industry partners to drive operational excellence and innovation throughout their organizations. Our aim is to support our clients, and the patients they serve. Visit for more information. 

Learn more 

Intelligencia’s mission is bringing new therapies to patients faster. We combine exceptional data with the computational power of AI to improve your probability of clinical success and enhance your sourcing of external innovation. Our customers – large pharmaceutical companies, and biotechs ranging from multi-billion large-cap to emerging preclinical – use Intelligencia’s platform to (i) assess the probability of success (PTRS) of their development programs and minimize any risks, (ii) optimize trial design and evaluate additional indications for a clinical asset, (iii) evaluate the relative attractiveness external assets, and (iv) predict likely future areas of scientific innovation. With offices in the US and Europe, our team is made up of industry veterans, data scientists, bioinformaticians, software engineers, biologists, and drug developers.
IQHQ is giving progress a home, empowering the life science community to thrive and succeed by creating environments that inspire innovation and drive progress and growth. IQHQ’s focus is to acquire, develop and operate life science districts in the innovation hubs of San Francisco, San Diego and Boston in the United States, and the Golden Triangle in the United Kingdom. IQHQ has offices in San Diego and Boston. To learn more, visit
For life sciences leaders seeking to clear their path to success, McDermott Will & Emery is an industry-leading law firm offering mission-first business solutions that are equally informed by market intelligence and proven experience. Currently representing fifteen of the world’s top 20 biopharma companies, we harness the power of collaboration to bring the right combination of people, skills and knowledge to bear at the right time. Composed of top lawyers with demonstrated strength across intellectual property, transactional and litigation law and FDA regulatory, we’re a purpose-built team of thought leaders united by a passion for our work. For decades, we have embraced the value of focused knowledge, harnessing both the particular skills of individuals and the collective experience of our team. This makes us uniquely qualified to help you move business initiatives across the finish line when it matters and anticipate what’s next.

Prescient® specializes in decision support and product/portfolio strategy, helping you realize your molecules’ potential, shape strategic plans and make successful decisions. With us, your molecules have greater winning potential than the same science held by your competitors. 

With eight global locations and 350+ experts, Prescient partners with the top biopharma companies, fastest-growing mid-caps and emerging biotechs, delivering clinical and commercial expertise.

Prescient is a portfolio company of Bridgepoint Development Capital (2021) and Baird Capital (2017).


As a global company, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug, biology discovery, preclinical testing and clinical research services, cell and gene therapies, helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.  



As a trusted strategic advisor for the healthcare & life sciences community, Bank of America helps deliver innovative ideas, advice and solutions needed to streamline your banking and support your continued growth pre and post regulatory approval, domestically and globally.  We leverage our breadth of expertise and client driven experience so you can rely on us to help you elevate your company to the next level.  For more information visit:

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to

Nurturing Innovation 


Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our 15,000 employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.


Accelerate your deal process securely with Venue, our award-winning virtual data room. Our quick set up and intuitive VDR platform leverages AI technology and machine learning to accelerate deal closing. Continually optimized for security, productivity and usability, our VDRs are reinforced by our regional experts–an extension of your deal team. 



The delivery of personalized healthcare is causing a power shift with new entrants disrupting incumbents. Innovation, productivity and access to patients challenge every link in the life sciences value chain, from RD and product supply to product launch and patient-centric operating models. 

EY Life Sciences brings together a worldwide network of 23,000 sector professionals to anticipate trends, identify implications and help clients create competitive advantage in a health outcomes-driven ecosystem. To learn more please visit




Jennifer Brown
Managing Director, Ernst & Young, LLP
[email protected]
Dan Kleeburg
Partner, Assurance, Ernst & Young, LLP
Jaimie Tanner
Senior Manager, Assurance, Ernst & Young, LLP
[email protected]

T3 Savills is the consultant of choice for life science companies seeking unbiased, holistic, and strategic advice on all aspects of the real estate decision-making process. Our team of former scientists and operators are familiar with the inner workings of various types of labs, who will help translate scientific complexities into efficient facility requirements that attract and retain the best talent while optimizing for cost. 




Bench International is the oldest woman-founded executive search firm serving the Life Science and Healthcare sectors. The firm is also one of the most renowned experts in diversity recruitment at the board and executive level, as well as in R&D leadership. Bench’s scorecard reflects over $150 billion in successful client exits, a 98% project completion record, with a 75% retention for five or more years. 33% of all leaders placed in Bench’s 45+ year history have been gender and ethnically diverse.

Learn more:

Global Affairs Canada

We define, shape and advance Canada’s interests and values in a complex global environment. We manage diplomatic relations, promote international trade and provide consular support. We lead international development, humanitarian, and peace and security assistance efforts. We also contribute to national security and the development of international law.

JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations worldwide. JPMorgan Chase had $3.7 trillion in assets and $280.7 billion in stockholders’ equity as of March 31, 2021. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S. and globally many of the world’s most prominent corporate, institutional and government clients.

Learn more:

Longfellow partners with leading universities, institutions and companies to deliver holistic real estate solutions for life sciences and technology organizations. It’s not just about building structures. It’s about the people and companies inside them that are making the innovation economy in real time. We want our places to sing with creativity and connections. We believe in the power of the work environment to nurture and grow both companies and

SMBC Group is one of the largest financial institutions headquartered in Japan. Sumitomo Mitsui Financial Group, Inc. (SMFG) is the holding company of SMBC Group. As of June 30, 2021, its total assets were $2.11 trillion. In the Americas, backed by the capital strength of SMBC Group and the value of its relationships in Asia, the Group offers a range of commercial and investment banking services to its corporate, institutional, and municipal clients.